IMPORTANT: The Ellipta demonstration device is intended for demonstrating only and not for patient use. Patients should not put the demonstration inhaler in their mouth.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
Anoro, Incruse, Relvar, Trelegy and Ellipta are registered trademarks of the GlaxoSmithKline group of companies
N.M. Last updated: November 2017. UK/RESP/0203/17(1)
Get in touch
To discuss our products, supply, educational events or any other information